Bristol-Myers Squibb Company (BMY) · page 4 of 16
The slide uses a line chart to illustrate the 'patent cliff' phenomenon, contrasting the steep decline of small molecules with the relative stability of biologics.
Shareholder letter · comparison_table · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/7
callout 0/1 chart 1/1 metric 0/1 paragraph 2/2 source-note 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 7
callout line primary paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1